Demographic, clinical, and geographical factors associated with lack of receipt of physician recommended chemotherapy in women with breast cancer in Texas.
Breast cancer
Breast cancer mortality
Poverty
Receipt of chemotherapy
Spatial analysis
Journal
Cancer causes & control : CCC
ISSN: 1573-7225
Titre abrégé: Cancer Causes Control
Pays: Netherlands
ID NLM: 9100846
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
29
07
2018
accepted:
22
02
2019
pubmed:
15
3
2019
medline:
4
6
2019
entrez:
15
3
2019
Statut:
ppublish
Résumé
Identifying demographic, clinical, and geographical factors that contribute to disparities in the receipt of physician recommended chemotherapy in breast cancer patients. The Texas Cancer Registry was used to identify women aged ≥ 18 years with invasive breast cancer diagnosed from 2007 to 2011 who received a recommendation for chemotherapy. Multivariable logistic regression was performed to determine associations between demographic and clinical factors and the receipt of chemotherapy. Cox proportional regression was used to estimate the hazard ratio (HR) for overall survival. Spatial analysis was conducted using Poisson models for breast cancer mortality and receipt of chemotherapy. Age ≥ 65 years, residence in areas with > 20% poverty index, and early disease stage were associated with lack of receipt of chemotherapy (all p < 0.001). Lack of receipt of chemotherapy was associated with decreased overall survival (HR 1.33, 95% CI 1.12-1.59, p = 0.001). A 38-county cluster in West Texas had lower receipt of chemotherapy (relative risk 0.88, p = 0.02) and increased breast cancer mortality (p = 0.03) compared to the rest of Texas. Older age, increased poverty and rural geographical location are barriers to the receipt of chemotherapy. Interventions that target these barriers may reduce health disparities and improve breast cancer survival.
Identifiants
pubmed: 30868330
doi: 10.1007/s10552-019-01151-9
pii: 10.1007/s10552-019-01151-9
pmc: PMC7239038
mid: NIHMS1582322
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
409-415Subventions
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Références
Breast Cancer Res Treat. 2018 Jan;167(1):1-8
pubmed: 28884392
J Clin Oncol. 2012 Sep 1;30(25):3058-64
pubmed: 22869890
J Clin Oncol. 2014 Sep 1;32(25):2758-64
pubmed: 25071111
Arch Intern Med. 2006 Nov 13;166(20):2244-52
pubmed: 17101943
Int J Health Geogr. 2005 May 18;4:11
pubmed: 15904524
Aust J Rural Health. 2012 Oct;20(5):259-64
pubmed: 22998200
J Clin Oncol. 2015 Oct 1;33(28):3177-85
pubmed: 26304878
J Environ Public Health. 2012;2012:959343
pubmed: 22518193
J Clin Oncol. 2015 Jul 20;33(21):2337-44
pubmed: 25940726
J Oncol Pract. 2017 Apr;13(4):e353-e394
pubmed: 28326862
Eur J Cancer Care (Engl). 2016 Jan;25(1):93-8
pubmed: 25871852
Cancer. 2009 Jul 1;115(13):2999-3008
pubmed: 19452539
Breast Cancer Res Treat. 2013 Jan;137(1):247-60
pubmed: 23139057
J Clin Oncol. 2005 Sep 20;23(27):6639-46
pubmed: 16170171
N C Med J. 2014 Jul-Aug;75(4):239-46
pubmed: 25046086
Cancer. 2008 Jan 1;112(1):171-80
pubmed: 18040998